BeStock  

Schrodinger SDGR

US equityMarket cap rank #2783AI medical concept stocks
$22.93 −$3.41 (-12.95%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $23.25 +1.40%
Open$25.82
Prev close$26.34
Day range$22.75 – $26.30
Volume1.88M
Market cap$1.72B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership103.1%-0.54 pts vs. prior quarter
Institutions holding317+30 vs. prior quarter
Insider trades (recent)27 buys / 20 sellsNet buying
ARK fund activity+4,717 sh1 recent transactions · last 13 Aug 2026
Short interest13.03% of floatDays to cover 5.8 · as of 30 Oct 2026
Short-sale volume share19.4%5-day average of daily volume

Short-sale volume as % of daily volume

10%16%21%27%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$6.70M (7 inflow days, 13 outflow days).

Net flow by order size, last 20 sessions

−$6.8MSuper+$105.3KBig−$2.0MMid+$954.1KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 52.4% of shares outstanding.

Largest holders

  • Bill & Melinda Gates Foundation Asset Trust21.51%
  • BlackRock13.71%
  • Rubric Capital Management LP8.52%
  • Vanguard Portfolio Management, LLC5.14%
  • Vanguard Capital Management, LLC3.56%
  • UBS Asset Management3.45%
  • Sumitomo Mitsui Trust Asset Management3.41%
  • Amova Asset Management3.40%

By investor type

  • Mutual Fund59.23%
  • Foundation21.51%
  • Hedge Fund15.84%
  • Public Company3.31%
  • Individual/Insider2.52%
  • Private Company1.55%
  • Government Pension Fund0.89%
  • Insurance Company0.60%

Reported short interest has fallen from 15.28% to 13.03% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
FMR Mutual Fund 2026/Q3 +546,634 0.7%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +400,643 0.5%
Heirloom Wealth Management LLC Mutual Fund 2026/Q3 +327,828 0.4%
Tairen Capital Limited Hedge Fund 2026/Q3 +310,912 0.4%
ARK Investment Management LLC Mutual Fund 2026/Q3 +220,888 3.2%
1832 Asset Management L.P. Mutual Fund 2026/Q3 +200,000 0.3%
Edgestream Partners, L.P. Hedge Fund 2026/Q3 +169,757 0.2%
Public Sector Pension Investment Board Government Pension Fund 2026/Q3 +154,824 0.5%
Connor, Clark & Lunn Investment Management Ltd. Mutual Fund 2026/Q3 +106,472 0.4%
Franklin Resources Mutual Fund 2026/Q3 +99,149 0.1%
Dimensional Fund Advisors Mutual Fund 2026/Q3 +96,081 1.0%
Lisanti Capital Growth, LLC Mutual Fund 2026/Q3 +92,600 0.1%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +275,513 0.4%
AQR Capital Management Hedge Fund 2026/Q3 +1,498,664 2.6%
BlackRock Mutual Fund 2026/Q3 +843,164 14.1%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
10 Nov 2026 Robert Abel Executive VP, Chief Scientific Officer of Platform and Head of Modeling R&D Open Market Disposition -1,678 $34.00 4,395
10 Nov 2026 Robert Abel Executive VP, Chief Scientific Officer of Platform and Head of Modeling R&D Derivative Exercise and Sale -21,927 $34.00 4,395
10 Nov 2026 Paul Davie Executive VP, Chief Commercial Officer, Global Head of Software Sales & Marketing Other Acquisition +18,400 – 18,400
10 Nov 2026 Paul Davie Executive VP, Chief Commercial Officer, Global Head of Software Sales & Marketing Other Derivative Acquisition +110,600 $31.52 110,600
8 Nov 2026 Yvonne Tran Corporate Secretary, Chief Legal & People Officer Derivative Exercise and Sale -32,000 $33.11 10,492
16 Sep 2026 Karen Akinsanya President, Head of Therapeutics R&D and Chief Strategy Officer & Partnerships Derivative Exercise and Sale -31,599 $30.00 6,411
15 Jul 2026 Richie Jain Chief Financial Officer Automatic Disposition -875 $15.60 7,723
30 Jun 2026 Mannix Aklian Intent to Sell (Form 144) -1,136 $16.68 –
25 Jun 2026 Richard Friesner Co-Founder, Scientific Advisory Chairman and Director Other Acquisition +679,373 – 1,405,477
25 Jun 2026 Richard Friesner Co-Founder, Scientific Advisory Chairman and Director Other Disposition -679,373 – 1,405,477
21 Jun 2026 Michael Lynton Independent Chairperson Other Acquisition +8,141 – 8,141
21 Jun 2026 Michael Lynton Independent Chairperson Other Derivative Acquisition +13,313 $15.23 13,313
21 Jun 2026 Gary Ginsberg Independent Director Other Acquisition +8,141 – 8,141
21 Jun 2026 Gary Ginsberg Independent Director Other Derivative Acquisition +13,313 $15.23 13,313
21 Jun 2026 Gary Sender Independent Director Other Acquisition +8,141 – 8,141
21 Jun 2026 Gary Sender Independent Director Other Derivative Acquisition +13,313 $15.23 13,313
21 Jun 2026 Arun Oberoi Independent Director Other Acquisition +8,141 – 8,141
21 Jun 2026 Arun Oberoi Independent Director Other Derivative Acquisition +13,313 $15.23 13,313
21 Jun 2026 Rosana Kapeller-Libermann Independent Director Other Acquisition +8,141 – 8,141
21 Jun 2026 Rosana Kapeller-Libermann Independent Director Other Derivative Acquisition +13,313 $15.23 13,313

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 9,750,213 13.0% 5.8
15 Oct 2026 10,402,258 13.9% 3.4
30 Sep 2026 10,131,631 13.5% 3.1
15 Sep 2026 11,169,335 14.9% 8.7
31 Aug 2026 11,089,264 14.8% 11.8
14 Aug 2026 11,426,561 15.3% 8.4

Discussion

No comments yet — be the first to weigh in on SDGR.

Sign in to join the discussion.

Scroll to Top